PIGV
(Phosphatidylinositol Glycan Anchor Biosynthesis, Class V (PIGV))
Spezies
Human
Quelle
Synthetic
Applikation
Blocking Peptide (BP), Immunohistochemistry (IHC), Western Blotting (WB)
Produktmerkmale
This is a synthetic peptide designed for use in combination with anti-PIGV antibody (Catalog #: ARP47358_T100). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
Each Investigator should determine their own optimal working dilution for specific applications.
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Lyophilized
Rekonstitution
Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
Konzentration
1 mg/mL
Buffer
Final peptide concentration is 1 mg/mL in PBS.
Handhabung
Avoid repeated freeze-thaw cycles.
Lagerung
-20 °C
Informationen zur Lagerung
For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
Target
PIGV
(Phosphatidylinositol Glycan Anchor Biosynthesis, Class V (PIGV))
Synonyme
GPI-MT-II Peptide, HPMRS1 Peptide, PIG-V Peptide, B330013B03 Peptide, D430024F16Rik Peptide, RGD1309526 Peptide, phosphatidylinositol glycan anchor biosynthesis class V Peptide, zinc finger DHHC-type containing 18 Peptide, phosphatidylinositol glycan anchor biosynthesis, class V Peptide, PIGV Peptide, ZDHHC18 Peptide, Pigv Peptide
Hintergrund
Glycosylphosphatidylinositol (GPI) is a complex glycolipid that anchors many proteins to the cell surface. The biosynthetic pathway of GPI is mediated by sequential addition of sugars and other components to phosphatidylinositol. PIGV adds the second mannose to the GPI core.